| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/24/1998 | US5840713 Therapy for tissue membrane insufficiency |
| 11/24/1998 | US5840712 Water soluble vitamin B12 receptor modulating agents and methods related thereto |
| 11/24/1998 | US5840707 A protein or peptide formulation comprising a polynucleotide component, a negatively charge lipid component and a divalent cation component |
| 11/24/1998 | US5840701 Antiischemic agents and macomolecules |
| 11/24/1998 | US5840700 Methods of producing transfer factor |
| 11/24/1998 | US5840699 Antitumor agents |
| 11/24/1998 | US5840698 Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use |
| 11/24/1998 | US5840697 Peptide inhibitors of calmodulin |
| 11/24/1998 | US5840696 Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ) |
| 11/24/1998 | US5840695 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 11/24/1998 | US5840693 Vascular endothelial growth factor-B |
| 11/24/1998 | US5840692 Peptide fragments and analogs of thrombospondin |
| 11/24/1998 | US5840691 Administering to suppress inflammation, inhibit infiltration of leukocytes into tissue |
| 11/24/1998 | US5840690 Treating hyperproliferative skin disorders, enhancing wound healing, stimulating hair growth |
| 11/24/1998 | US5840689 Nervous system disorders and central nervous system |
| 11/24/1998 | US5840688 Having sequences corresponding to specific portions of apolipoprotein a-iv |
| 11/24/1998 | US5840687 Polypeptides for kinases |
| 11/24/1998 | US5840686 Pigment epithelium-derived factor: characterization of its novel biological activity and sequences encoding and expressing the protein and methods of use |
| 11/24/1998 | US5840685 Intravaginal delivery of biologically active polypeptides |
| 11/24/1998 | US5840684 Bactericides for vancomycin resistant bacteria |
| 11/24/1998 | US5840683 Antitumor |
| 11/24/1998 | US5840682 Peptide antagonists of neurotensin |
| 11/24/1998 | US5840681 X-ray induced skin damage protective composition |
| 11/24/1998 | US5840680 ASPB28 insulin crystals |
| 11/24/1998 | US5840679 Method of inhibiting P-selectin ligand activity |
| 11/24/1998 | US5840673 Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of p53-related tumors |
| 11/24/1998 | US5840588 Binding hapten to erythrocyte or latex particles; mixing sample with antibody against hapten, combining antibody with bound hapten; agglutination occurs only when lack of hapten in sample; simplicity, high speed, specificity |
| 11/24/1998 | US5840585 Purifying antibody that specifically binds to native rh antigen by contacting samply with immobilized antigenically-active rh antigen then eluting |
| 11/24/1998 | US5840579 Cis or trans acting suppressors; cancer drugs and therapy |
| 11/24/1998 | US5840574 Nucleotide sequence including coding portion of marek*s disease virus gene |
| 11/24/1998 | US5840569 Human GTP-binding proteins |
| 11/24/1998 | US5840568 Screening for hodgkin's disease using a nucleic acid molecule which encodes a hodgkin's disease specific antigen |
| 11/24/1998 | US5840566 Isolation of a gene encoding human thyrotropin beta subunit |
| 11/24/1998 | US5840565 Methods for enhancing the production of viral vaccines in PKR-deficient cell culture |
| 11/24/1998 | US5840564 Variant having amino acid substitutions or deletions and at least a protease domain and n-terminal region associated with fibrin binding; drugs for vascular disorders |
| 11/24/1998 | US5840563 Method for growing swine infertility and respiratory syndrome virus |
| 11/24/1998 | US5840560 Glucose kinase from streptococcus pneumoniae |
| 11/24/1998 | US5840559 Isolated and purified polynucleotide sequence coding polypeptide; hybridization probes; vectors and host cells for gene expression; anticancer and antitumor agents |
| 11/24/1998 | US5840545 Immunoglubulins |
| 11/24/1998 | US5840544 DNA encoding rantes homolog from prostate |
| 11/24/1998 | US5840540 Sequence determination and expression of familial alzheimer's disease membrane protein |
| 11/24/1998 | US5840538 Lgt |
| 11/24/1998 | US5840537 Polynucleotides which identify and encode a human vesicle transport protein (nvtp-1); used in the diagnosis, prevention, and treatment of cancer and immunde disorders |
| 11/24/1998 | US5840536 Isolated polynucleotide coding for human cytoplasmic signalling protein and hybridizing to complementary polynucleotide coding for protein containing pleckstrin homology domain; preparing pure human protein from culture |
| 11/24/1998 | US5840535 DNA encoding a zinc ring protein |
| 11/24/1998 | US5840534 Pure polynucleotide encoding an amino acid sequence; culturing cell containing expression vector; gene family important in cell division; preventing genetic defects |
| 11/24/1998 | US5840533 Tissue plasminogen activator |
| 11/24/1998 | US5840531 Expression of mammalian islet cell neogenesis associated protein; vectors, probes, antisense constructs |
| 11/24/1998 | US5840530 DNA encoding receptors for the beta-2 chain of human IL-12 |
| 11/24/1998 | US5840527 Lung surfactant proteins |
| 11/24/1998 | US5840525 P185 receptor implicated in cellular growth |
| 11/24/1998 | US5840524 Antiinflammatory agents is the culture product from genetic engineered cell; receptor binding activity |
| 11/24/1998 | US5840522 Recombinant lectins |
| 11/24/1998 | US5840517 Process for preparing obesity protein analogs |
| 11/24/1998 | US5840516 Screening compounds as an inhibitor of excitatory amino acid transport in cells, transforming cell culture for genetic expression, analyzing transformed cell culture |
| 11/24/1998 | US5840514 Using a fibronectin-depleted substrate and peptide invasion-inducing agent |
| 11/24/1998 | US5840511 Methods comprising calcium independent cytosolic phospholipase A/B enzymes |
| 11/24/1998 | US5840509 Protease and related nucleic acid compounds |
| 11/24/1998 | US5840498 Antibiotic cryptdin peptides and methods of their use |
| 11/24/1998 | US5840497 Single stranded oligonucleotide containing 5-methyl deoxycytosine hybridizes during s phase to promoter containing cpg doublets causing inheritable deactivation; reversed by demethylating agent |
| 11/24/1998 | US5840496 Method for diagnosing endometrial cancer |
| 11/24/1998 | US5840495 Methods for diagnosis of conditions associated with elevated levels of telomerase activity |
| 11/24/1998 | US5840493 Diagnosis of late onset diabetes by detection of mutations in adenosine triphosphate synthase or transfer rna (lys) genes in a biological sample; labelled nucleotide sequences as detectors; accuracy |
| 11/24/1998 | US5840481 Transforming host cells with expression vector; gene product disrupts an essential activity of virus |
| 11/24/1998 | US5840477 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 11/24/1998 | US5840344 Monoclonal antibodies having property of causing apoptosis |
| 11/24/1998 | US5840340 Oligopeptides with fragrance, cosmetics and dye |
| 11/24/1998 | US5840331 Use of γ-hydroxybutyrate for the stimulation of sleep-related secretion growth hormone and prolactin |
| 11/24/1998 | US5840325 Osteogenic devices |
| 11/24/1998 | US5840317 Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen |
| 11/24/1998 | US5840316 Desensitization |
| 11/24/1998 | US5840311 Administering hepatocyte growth factors to treat fibrosis disorder; increases collagenase activity |
| 11/24/1998 | US5840305 Administering anti-cyclophilin antibody |
| 11/24/1998 | US5840304 Amino acid sequences and codes for t-cells |
| 11/24/1998 | US5840302 Treatment of bacterially-induced inflammatory diseases |
| 11/24/1998 | US5840301 Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors |
| 11/24/1998 | US5840300 Methods and compositions comprising single chain recombinant antibodies |
| 11/24/1998 | US5840299 Binding and treatment of multiple sclerosis |
| 11/24/1998 | US5840298 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 11/24/1998 | US5840296 Engineered cytotoxic ribonuclease A |
| 11/24/1998 | US5840295 Obtained from injured fish optic nerves; converts interleukin-2 to a dimeric form having oligodendrocyte cytotoxic activity; facilitates regeneration of injured nerves of central nervous system |
| 11/24/1998 | US5840283 Composition and method for treating diseased nails |
| 11/24/1998 | US5840054 Method for obstructing lacrimal canaliculi with infusable solution or dispersion |
| 11/24/1998 | US5839443 Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation |
| 11/24/1998 | CA2088579C Agents that bind to vcam-1 and uses thereof |
| 11/24/1998 | CA2020439C Modified biologically active protein |
| 11/23/1998 | CA2232810A1 Novel compounds |
| 11/23/1998 | CA2232809A1 Novel compounds |
| 11/23/1998 | CA2232808A1 Novel compounds |
| 11/23/1998 | CA2232807A1 Novel compounds |
| 11/23/1998 | CA2230996A1 Novel compounds |
| 11/23/1998 | CA2221837A1 A novel human gene similar to a secreted protein frizb (atg-1639) |
| 11/23/1998 | CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1 |
| 11/23/1998 | CA2206047A1 Immunomodulating compositions for the treatment of viral disorders |
| 11/22/1998 | CA2231017A1 A member of the frzb family, frazzled |
| 11/22/1998 | CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9 |
| 11/21/1998 | CA2232811A1 Novel def1 |
| 11/21/1998 | CA2229436A1 A human gene similar to a secreted murine protein sdf5 |
| 11/21/1998 | CA2224473A1 A novel human gene similar to a secreted murine protein sdf5 |
| 11/19/1998 | WO1998051825A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |